Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02800785 · ClinicalTrials.gov registry record · NA
The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 1,552
- Enrollment target
NCT02800785 is a NA study that has completed, run by University of Washington. The registered enrollment target is 1,552 participants.
The verdict
NCT02800785, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,552 participants
- Enrollment target
Study Summary
For the past 130 years, appendectomy has been the standard treatment for appendicitis. Recent studies from Europe have challenged the notion that surgery is the best option, showing that antibiotics alone can treat appendicitis without a need for appendectomy in as many as 3 out of 4 patients and without safety issues for up to one year of follow up. Despite these results, it remains to be determined if the antibiotic strategy is as good as an appendectomy for the outcomes that most patients care about. The Patient-Centered Outcomes Research Institute (PCORI)-funded Comparison of Outcomes of Drugs and Appendectomy (CODA) trial will be the first American, and largest-ever randomized trial of the issue and its results should help surgeons and patients make more informed healthcare decisions.
Interventions
- PROCEDURE Appendectomy
- DRUG Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,552 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02800785
The ClinicalTrials.gov registry entry for NCT02800785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,552 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Appendectomy is the first listed.
NCT02800785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02800785 about?
NCT02800785 is a clinical study titled "The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial". For the past 130 years, appendectomy has been the standard treatment for appendicitis. Recent studies from Europe have challenged the notion that surgery is the best option, showing that antibiotics alone can treat appendicitis without a need for appendectomy in as many as 3 out of 4 patients and wi...
What is the current status of trial NCT02800785?
This trial is currently completed. It is a NA study. The enrollment target is 1,552 participants. The study started on 2016-05. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT02800785?
The interventions under investigation include: Appendectomy (PROCEDURE), Cefoxitin, Ertapenem, Moxifloxacin, Tigecycline, Ticarcillin-Clavulanic Acid; Metronidazole plus Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, Ciprofloxacin, or Levofloxacin (DRUG).
Who is sponsoring clinical trial NCT02800785?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.